DASFREE: Treatment-free remission (TFR) after discontinuation of dasatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) and deep molecular response (DMR) Meeting Abstract
| Authors: | Shah, N. P.; Garcia-Gutiérrez, V.; Jiménez-Velasco, A.; Larson, S.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gómez-Casares, M. T.; Luciano, L.; Nicolini, F. E.; Mauro, M. J.; Sy, O.; Martin-Regueira, P.; Lipton, J. H. |
| Abstract Title: | DASFREE: Treatment-free remission (TFR) after discontinuation of dasatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) and deep molecular response (DMR) |
| Meeting Title: | 7th Annual Meeting of the Society of Hematologic Oncology (SOHO 2019) |
| Keywords: | imatinib; cml; dasatinib; chronic; myelogenous leukemia; treatment-free remission; cml-cp |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 19 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Sep 11-14 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-09-01 |
| Start Page: | S299 |
| Language: | English |
| ACCESSION: | WOS:000483480700290 |
| DOI: | 10.1016/j.clml.2019.07.253 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CML-283 -- Source: Wos |
